AU4312593A - Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease - Google Patents

Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease

Info

Publication number
AU4312593A
AU4312593A AU43125/93A AU4312593A AU4312593A AU 4312593 A AU4312593 A AU 4312593A AU 43125/93 A AU43125/93 A AU 43125/93A AU 4312593 A AU4312593 A AU 4312593A AU 4312593 A AU4312593 A AU 4312593A
Authority
AU
Australia
Prior art keywords
parkinson
disease
treatment
sexual dysfunction
memory disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43125/93A
Inventor
Robin Bradshaw Fears
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929210595A external-priority patent/GB9210595D0/en
Priority claimed from GB929210576A external-priority patent/GB9210576D0/en
Priority claimed from GB929210594A external-priority patent/GB9210594D0/en
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU4312593A publication Critical patent/AU4312593A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
AU43125/93A 1992-05-18 1993-05-04 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease Abandoned AU4312593A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB929210595A GB9210595D0 (en) 1992-05-18 1992-05-18 Medical use
GB929210576A GB9210576D0 (en) 1992-05-18 1992-05-18 Medical use
GB929210594A GB9210594D0 (en) 1992-05-18 1992-05-18 Medical use
GB9210594 1992-05-18
GB9210595 1992-05-18
GB9210576 1992-05-18

Publications (1)

Publication Number Publication Date
AU4312593A true AU4312593A (en) 1993-12-13

Family

ID=27266192

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43125/93A Abandoned AU4312593A (en) 1992-05-18 1993-05-04 Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease

Country Status (4)

Country Link
EP (1) EP0641202A1 (en)
JP (1) JPH07506823A (en)
AU (1) AU4312593A (en)
WO (1) WO1993023035A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6395744B1 (en) 1994-04-22 2002-05-28 Queen's University At Kingston Method and compositions for the treatment or amelioration of female sexual dysfunction
US5807570A (en) * 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
FR2742149B1 (en) * 1995-12-11 1998-02-13 Inst Nat Sante Rech Med NOVEL 2-NAPHTAMIDE DERIVATIVES AND THEIR THERAPEUTIC APPLICATIONS
PT923551E (en) * 1996-08-27 2002-09-30 American Home Prod 4-AMINOETHOXY INDOLONE DERIVATIVES
US5945117A (en) * 1998-01-30 1999-08-31 Pentech Pharmaceuticals, Inc. Treatment of female sexual dysfunction
CN1297439A (en) * 1998-04-13 2001-05-30 美国家用产品公司 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
JP2002518435A (en) * 1998-06-22 2002-06-25 クイーンズ ユニバーシティ アット キングストン Methods and compositions for the treatment or amelioration of female sexual dysfunction
CA2251255A1 (en) * 1998-10-20 2000-04-20 Mcgill University The use of dopaminergic agents in the management of sexual dysfunction
AR030557A1 (en) 2000-04-14 2003-08-27 Jagotec Ag A TABLET IN MULTI-MAP OF CONTROLLED RELEASE AND TREATMENT METHOD
DE10041479A1 (en) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh New pharmaceutical composition for the administration of N-0923
DE10359528A1 (en) 2003-12-18 2005-07-28 Schwarz Pharma Ag (S) -2-N-propylamino-5-hydroxytetralin as a D3 agonist therapeutic
AP2006003823A0 (en) * 2004-05-26 2006-12-31 Pfizer Indazole and indolone derivatives and their use aspharmaceuticals
WO2012021629A2 (en) * 2010-08-11 2012-02-16 Philadelphia Health & Education Corporation Novel d3 dopamine receptor agonists to treat dyskinesia in parkinson's disease
CA2928429C (en) 2013-10-28 2022-08-30 Drexel University Aminoalkyl phenyl derivatives useful in the treatment of adhd and other cognitive disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8712073D0 (en) * 1987-05-21 1987-06-24 Smith Kline French Lab Medicament
FR2663638B2 (en) * 1990-04-06 1995-02-10 Institut Nal Sante Recherc Medic POLYPEPTIDES HAVING DOPAMINERGIC RECEPTOR ACTIVITY, NUCLEIC ACIDS ENCODING SUCH POLYPEPTIDES AND USE OF SUCH POLYPEPTIDES FOR SCREENING ACTIVE SUBSTANCES ON THESE POLYPEPTIDES.
GB9015095D0 (en) * 1990-07-09 1990-08-29 Smith Kline French Lab Therapeutic method

Also Published As

Publication number Publication date
WO1993023035A2 (en) 1993-11-25
JPH07506823A (en) 1995-07-27
WO1993023035A3 (en) 1994-03-03
EP0641202A1 (en) 1995-03-08

Similar Documents

Publication Publication Date Title
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
AU6406996A (en) Compositions for the treatment and diagnosis of body weight disorders, including obesity
AU3497295A (en) Compositions and methods for the treatment of body weight disorders, including obesity
HUP9800033A3 (en) Compositions for the treatment of dermatological disorders and methods for their use
EP0715851A3 (en) Substituted phenylpyrimidine derivatives, useful in the treatment of prevention of CNS disorders
IL116998A0 (en) Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
IL110204A0 (en) Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders
AU4312593A (en) Use of indolone derivatives for the treatment of memory disorders, sexual dysfunction and Parkinson's disease
EP0331620A3 (en) Agent for the treatment of parkinson's disease
AU2293992A (en) Indole derivatives, pharmaceutical compositions and methods of treating neurological and psychiatric disorders
AU3537893A (en) Indole and indazole derivatives, for the treatment and prophylaxis of cerebral disorders, their preparation and their use
AU2058697A (en) Treatment of sleep disorders
CA2347863A1 (en) Treatment of disorders of the outer retina
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
AU2693697A (en) Use of 2,5-dihydroxybenzenesulfonic derivatives for the manufacture of medicaments intended for the normalization of the endothelial function, for the treatment of sexual dysfunction and vascular complications of diabetes, as well as vascular disorders of endothelial origin
AU4517096A (en) The treatment of autoimmune disease using 2-amino purine derivatives
AU4476089A (en) Use of azepinone derivatives for the treatment of respiratory tract disorders
AU1807592A (en) New combination preparation for treatment of parkinson's disease
AU6678194A (en) Agents for the prevention and treatment of huntington's disease and other neurological disorders
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
GB9618300D0 (en) Glutamate receptor modulators and the treatment of psychiatric disorders
ITMI941939A0 (en) PURINE AND 8-AZAPURINE DERIVATIVES SUITABLE FOR THE THERAPEUTIC TREATMENT OF AIDS
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders